The levels of or the change of levels of ER, PR and HER2 were similar among cancers with different types of residual tumors after NCT, indicating that the impact of type II and type III on local recurrence and survival rate was not related to ER, PR or HER2 status. Here, ERBB2 is linked to cancer.